Prepare and decide
The ingredient name is only the start. Check the exact product before comparing the price.
SV and WR identify two versions of tesamorelin, with different doses; they cannot be swapped for each other.
As of September 2026, current U.S. tesamorelin labels cover tesamorelin (EGRIFTA SV) and tesamorelin (EGRIFTA WR).
Those labels do not describe blends with another peptide.
Ask for the exact name, rather than accepting a general description of peptide care.
Pharmacies cannot legally prepare tesamorelin to order under the U.S. rules in September 2026.
That rule applies because tesamorelin is a biologic, a legal category that includes protein medicines.
A lower quote does not change that rule.
As of September 2026, tesamorelin sold with words such as “for research use only” is not the approved medicine.
In the U.S., medicines are reviewed by an agency called the Food and Drug Administration (FDA).
FDA warning letters reviewed in September 2026 describe sellers offering unapproved medicines for people.
FDA said the sales broke U.S. law despite words such as “for research use only” on the labels.
Compounding names the preparation of a made-to-order medicine, as distinct from supplying a finished manufactured product.
A biologic is a category of medicine under U.S. law that includes protein medicines.
“FDA registered” refers to a business on the agency’s list of businesses.
A drug-directory listing is an entry for a product in a government medicine list.
As of September 2026, neither record proves FDA approval or permission to sell that product.
Ask which exact medicine is proposed and where the licence records can be checked.
Find the licence checksWeighing care for deep belly fat
Compare the named product first. A label, a badge or a discount cannot answer the whole question.